Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
LEGN
#1578
Legend Biotech Corporation American Depositary Shares
18.690
0
USD
+5.65%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+5.65%
Aylık Değişim
-0.95%
6 aylık değişim
-41.56%
Yıllık Değişim
-41.56%
Önceki Kapanış
17.690
0
Open
18.690
0
Bid
Ask
Low
18.690
0
High
18.690
0
Hacim
101
Piyasalar
ABD Borsası
Sağlık Hizmetleri
LEGN
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
133.01 M
154.23 M
165.07 M
181.91 M
183.65 M
184.94 M
715.57 M
Valuation ratios
Enterprise value
3.29 B
6.5 B
7.25 B
9.47 B
5.69 B
3.12 B
28.79 B
Price to earnings ratio
—
—
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
—
—
Price to book ratio
—
—
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.42
0.35
0.34
0.28
0.11
0.17
—
Return on equity %
1.08
0.82
0.6
0.41
0.17
0.3
—
Return on invested capital %
—
—
—
—
—
—
—
Gross margin %
100
3.17
-87.05 K
49.42
65.51
-38.57
—
Operating margin %
77.5
3.17
-178.49 K
32.36
71.29
13.27
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
401.02
447.17
595.13 K
181.75
28.22
28.85
—
Liquidity ratios
Quick ratio
3.67
3.38
3.66
6.83
4.54
1.91
—
Current ratio
3.68
3.39
3.69
6.92
4.62
1.96
—
Inventory turnover
—
—
10.8
9.68
9.99
14.21
—
Asset turnover
0.1
0.09
0
0.18
0.36
0.6
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
—
—
—
—
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
—
—
—
—
—
Net current asset value per share
—
—
—
—
—
—
—
Tangible book value per share
—
—
—
—
—
—
—
Working capital per share
—
—
—
—
—
—
—
Book value per share
—
—
—
—
—
—
—
Haberler
Germany stocks lower at close of trade; DAX down 1.59%
RBC Capital, Legend Biotech hisse hedefini düşürdü
RBC Capital lowers Legend Biotech stock price target on model updates
Raymond James, güçlü 4Ç sonuçları sonrası Legend Biotech hisse notunu korudu
Raymond James, güçlü 4Ç sonuçlarına rağmen Legend Biotech hisse notunu korudu
Raymond James reiterates Legend Biotech stock rating on strong Q4 results
Truist, Legend Biotech için Al tavsiyesini yineledi, hedef 70 dolar
Truist reiterates Buy on Legend Biotech stock, $70 target on capacity
Jefferies, Legend Biotech hissesi için tavsiyesini korudu
Jefferies reiterates Legend Biotech stock rating on Carvykti sales
Legend Biotech 4Ç 2025 sonuçları: CARVYKTI kârlı, 555 milyon dolar
Legend Biotech Q4 2025 slides: CARVYKTI turns profitable, $555M sales